James Hamilton
Förmögenhet: 18 M $ per 2026-05-31
Förmögenhet: 18 M $ per 2026-05-31
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. Dr. Hamilton is Chief Medical Officer, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Hamilton was Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton completed undergraduate studies at Miami University and earned an MBA and a doctorate from The Ohio State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-05 | 236 958 ( 0,17 % ) | 18 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-02-01 |
| Företag | Position | Slut |
|---|---|---|
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Grundare | - |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån